Characterization of Crohn's disease patients in Egypt: Risk factors for postoperative recurrence (A cohort study)

被引:1
|
作者
Kamel, Shimaa [1 ]
Sakr, Mohamed [1 ]
Hamed, Waleed [1 ]
Eltabbakh, Mohamed [1 ]
Sherief, Ahmed [1 ]
Rashad, Heba [1 ]
Elghamrini, Yasser [2 ]
Elbaz, Ahmed [1 ]
机构
[1] Ain Shams Univ, Dept Trop Med Gastroenterol & Hepatol, Cairo, Egypt
[2] Ain Shams Univ, Dept Gen Surg, Cairo, Egypt
来源
关键词
Biological therapy; Characterizations; Crohn's disease; Montreal classification; Postoperative recurrence; ANASTOMOTIC RECURRENCE; ILEOCOLIC RESECTION; CLINICAL RECURRENCE; PROGNOSTIC-FACTORS; SMALL-BOWEL; THERAPY; ASSOCIATION; MANAGEMENT; SURGERY; STRICTUREPLASTIES;
D O I
10.1016/j.amsu.2021.102781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of study to identify the characterizations of Crohn's disease in Egyptian patients and to determine its predictors for postoperative recurrence. Methods: We conducted a retrospective observational cohort study on 15 patients diagnosed as Crohn's disease with surgical interventions. Different characteristics of studied patients were analyzed to determine the risk factors for postoperative recurrence such as age at diagnosis, gender, smoking, main presenting symptom, Montreal classification, perianal disease, laboratory findings and protocol of management including surgical characteristics like age at operation, surgical indication, preoperative medication, surgical approach, and operative findings. Results: Nine of the studied patients (60%) suffered from clinical postoperative recurrence with mean duration of 23.5 +/- 40.6 months. In comparison the demographic, clinical, operative, and medical treatment data between patients with postoperative recurrence of Crohn's disease and those without recurrence, age at diagnosis (mean age 42.9 years) and age at operation (mean 44.7 years) were found statistically significant in postoperative recurrence group (p-value = 0.001). According to Montreal classification of Crohn's disease, patients >40 years were significantly found in postoperative recurrence group, while patients between 17 and 40 years were significantly found in postoperative non-recurrence group (p-value=0.007) and ileal location of Crohn's disease was found significantly in postoperative recurrent group (p-value=0.044). Postoperative biological therapy significantly decreased the incidence of postoperative recurrence in the current study (p-value=0.041). Conclusions: Age at diagnosis, age at operation, ileal location of Crohn's disease can significantly predict postoperative recurrence. Also, postoperative biological therapy can significantly decrease the incidence of postoperative recurrence.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
    Aguas, Mariam
    Bastida, Guillermo
    Cerrillo, Elena
    Beltran, Belen
    Iborra, Marisa
    Sanchez-Montes, Cristina
    Munoz, Fernando
    Barrio, Jesus
    Riestra, Sabino
    Nos, Pilar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (32) : 4391 - 4398
  • [32] Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission
    Marion, Lirsac
    Amelie, Biron
    Zoubir, Djerada
    Guillaume, Cadiot
    Elise, Morcos-Sauvain
    Hedia, Brixi
    Saint Margaux, Le
    Aude, Marchal
    Camille, Boulagnon-Rombi
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (09) : 1395 - 1404
  • [33] Risk factors for endoscopic postoperative recurrence in patients with Crohn's Disease: a protocol for systematic review and meta-analysis
    Ma, Dongchi
    Li, Yu
    Li, Ling
    Yang, Lili
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [34] Postoperative recurrence of Crohn's disease: predictive factors and medical care
    Hellara, O.
    Ben Mansour, W.
    Ben Chaabene, N.
    Smaili, R.
    Melki, W.
    Loghmari, M. H.
    Bdioui, F.
    Safer, L.
    Saffar, H.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2013, 7 (04): : 165 - 175
  • [35] Reproducibility of the main prognostic factors for postoperative recurrence in a cohort of patients with Crohn's disease under anti-Tnf therapy
    Raimundo Fernandes, S.
    Correia, L.
    Baldaia, C.
    Moura Santos, P.
    Rita Goncalves, A.
    Valente, A.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S405 - S405
  • [36] RISK FACTORS ASSOCIATED WITH INTESTINAL FAILURE IN CROHN'S DISEASE PATIENTS: A RETROSPECTIVE COHORT STUDY
    Al-Shakarchi, Nader
    Khetan, Tanvi
    Fragkos, Konstantinos C.
    Rahman, Farooq
    GUT, 2022, 71 : A37 - A38
  • [37] Characterization of risk factors and postoperative pharmacological prophylaxis patterns affecting re-resection in Crohn's disease with surgical recurrence
    Ge, Xiaolong
    Liu, Huaying
    Liu, Wei
    Qi, Weilin
    Ye, Linna
    Cao, Qian
    Bai, Rongpan
    Zhou, Wei
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2025, 40 (01)
  • [38] CHRONOLOGIC AGE IS NOT ASSOCIATED WITH RISK OF POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE
    El Halabi, Jessica
    Bachour, Salam P.
    Shah, Ravi S.
    Joseph, Abel
    Cohen, Benjamin L.
    Rieder, Florian
    Achkar, Jean-Paul
    Philpott, Jessica
    Qazi, Taha
    Lightner, Amy L.
    Hull, Tracy L.
    Lipman, Jeremy M.
    Holubar, Stefan D.
    Regueiro, Miguel D.
    Click, Benjamin
    GASTROENTEROLOGY, 2022, 162 (07) : S102 - S103
  • [39] Non-invasive assessment of postoperative disease recurrence in Crohn's Disease: A multicenter, prospective cohort study
    Furfaro, F.
    Zilli, A.
    Craviotto, V.
    Aratari, A.
    Bezzio, C.
    Gilardi, D.
    D'Amico, F.
    Saibeni, S.
    Papi, C.
    Peyrin-Biroulet, L.
    Fiorino, G.
    Danese, S.
    Allocca, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S074 - S074
  • [40] NON-INVASIVE ASSESSMENT OF POSTOPERATIVE DISEASE RECURRENCE IN CROHN'S DISEASE: A MULTICENTER, PROSPECTIVE COHORT STUDY
    Furfaro, F.
    Zilli, A.
    Craviotto, V.
    Aratari, A.
    Bezzio, C.
    Gilardi, D.
    Loy, L.
    D'Amico, F.
    Saibeni, S.
    Papi, C.
    Peyrin-Biroulet, L.
    Fiorino, G.
    Danese, S.
    Allocca, M.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S206 - S206